These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 32092539)

  • 21. Comparative Pathogenesis of Bovine and Porcine Respiratory Coronaviruses in the Animal Host Species and SARS-CoV-2 in Humans.
    Saif LJ; Jung K
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32522830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Understanding of COVID-19 based on current evidence.
    Sun P; Lu X; Xu C; Sun W; Pan B
    J Med Virol; 2020 Jun; 92(6):548-551. PubMed ID: 32096567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inside China and COVID-19: Questions and answers.
    Jiang R
    Travel Med Infect Dis; 2020; 34():101640. PubMed ID: 32217104
    [No Abstract]   [Full Text] [Related]  

  • 24. Organoids of human airways to study infectivity and cytopathy of SARS-CoV-2.
    Elbadawi M; Efferth T
    Lancet Respir Med; 2020 Jul; 8(7):e55-e56. PubMed ID: 32446313
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter to the Editor: Priority Considerations of Patients with Peripheral Nerve Pathology in the Time of COVID-19.
    Murthy NK; Spinner RJ
    World Neurosurg; 2020 Aug; 140():493-494. PubMed ID: 32592967
    [No Abstract]   [Full Text] [Related]  

  • 26. Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.
    Wilson N; Kvalsvig A; Barnard LT; Baker MG
    Emerg Infect Dis; 2020 Jun; 26(6):1339-1441. PubMed ID: 32168463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ocular post-mortem findings in patients having died from COVID-19].
    Löffler KU; Reinhold A; Herwig-Carl MC; Tzankov A; Holz FG; Scholl HPN; Meyer P
    Ophthalmologe; 2020 Jul; 117(7):648-651. PubMed ID: 32519118
    [No Abstract]   [Full Text] [Related]  

  • 28. Deficiency of Tfh Cells and Germinal Center in Deceased COVID-19 Patients.
    Duan YQ; Xia MH; Ren L; Zhang YF; Ao QL; Xu SP; Kuang D; Liu Q; Yan B; Zhou YW; Chu Q; Liu L; Yang XP; Wang GP
    Curr Med Sci; 2020 Aug; 40(4):618-624. PubMed ID: 32767259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonal haematopoiesis and COVID-19: A possible deadly liaison.
    Shivarov V; Ivanova M
    Int J Immunogenet; 2020 Aug; 47(4):329-331. PubMed ID: 32515168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. It is too soon to attribute ADE to COVID-19.
    Sharma A
    Microbes Infect; 2020; 22(4-5):158. PubMed ID: 32268188
    [No Abstract]   [Full Text] [Related]  

  • 31. Friends or foes? The knowns and unknowns of natural killer cell biology in COVID-19 and other coronaviruses in July 2020.
    Manickam C; Sugawara S; Reeves RK
    PLoS Pathog; 2020 Aug; 16(8):e1008820. PubMed ID: 32845937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iron: Innocent bystander or vicious culprit in COVID-19 pathogenesis?
    Edeas M; Saleh J; Peyssonnaux C
    Int J Infect Dis; 2020 Aug; 97():303-305. PubMed ID: 32497811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microvascular injury and hypoxic damage: emerging neuropathological signatures in COVID-19.
    Jaunmuktane Z; Mahadeva U; Green A; Sekhawat V; Barrett NA; Childs L; Shankar-Hari M; Thom M; Jäger HR; Brandner S
    Acta Neuropathol; 2020 Sep; 140(3):397-400. PubMed ID: 32638079
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.
    Farshadpour F; Taherkhani R
    Med Princ Pract; 2021; 30(5):422-429. PubMed ID: 33882487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of protective role of Ultraviolet-B (UVB) radiation in reducing COVID-19 deaths.
    Moozhipurath RK; Kraft L; Skiera B
    Sci Rep; 2020 Oct; 10(1):17705. PubMed ID: 33077792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechano-genomic regulation of coronaviruses and its interplay with ageing.
    Uhler C; Shivashankar GV
    Nat Rev Mol Cell Biol; 2020 May; 21(5):247-248. PubMed ID: 32242128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-Dependent Enhancement of SARS-CoV-2 Infection Is Mediated by the IgG Receptors FcγRIIA and FcγRIIIA but Does Not Contribute to Aberrant Cytokine Production by Macrophages.
    Maemura T; Kuroda M; Armbrust T; Yamayoshi S; Halfmann PJ; Kawaoka Y
    mBio; 2021 Oct; 12(5):e0198721. PubMed ID: 34579572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ADE and hyperinflammation in SARS-CoV2 infection- comparison with dengue hemorrhagic fever and feline infectious peritonitis.
    Cloutier M; Nandi M; Ihsan AU; Chamard HA; Ilangumaran S; Ramanathan S
    Cytokine; 2020 Dec; 136():155256. PubMed ID: 32866898
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies.
    Ziganshina MM; Shilova NV; Khalturina EO; Dolgushina NV; V Borisevich S; Yarotskaya EL; Bovin NV; Sukhikh GT
    Viruses; 2023 Jul; 15(7):. PubMed ID: 37515270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection.
    Farouq MAH; Acevedo R; Ferro VA; Mulheran PA; Al Qaraghuli MM
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.